Degarelix in the Treatment of Endometriosis Recurrence
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The long acting GnRH antagonist degarelix will be tested for the treatment of women with
endometriosis recurrence compared with classical GnRH analog treatment. Pain symptom
disappearance and disease free time during follow-up will be the outcomes for establishing
which medical treatment is the best in endometriosis recurrence treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Centre for Endocrinology and Reproductive Medicine, Italy